Close Menu

NEW YORK – Rebounds from March's lows and the positive impacts of SARS-CoV-2 tests being launched by many diagnostics firms led to increases in share price for every company 360Dx Index but one in April.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.